Xavier Calvet retweeted
No hay déficit de vitamina D
No hay SIBO
No hay intolerancia a la fructosa
No hay intolerancias alimentarias basadas en test
Dejad de vivir engañados
Dejad de engañar a la población
Dejad de enriqueceros a costa de mentiras
Riesgos, indicaciones y aspectos técnicos de la colonoscopia en pacientes de edad avanzada o con fragilidad. Documento de posicionamiento de la SCD, SCGiG y la CAMFiC. authors.elsevier.com/a/1hCD3…
Link al texto completo de: “Indications and risk assessment of endoscopic examinations in elderly or frail people. Position paper of the Societat Catalana de Digestologia•••“ authors.elsevier.com/a/1g98D…
Xavier Calvet retweeted
Early cholecystectomy is not done in most patients in many centers (mine one) in spite of >40 years of clear cut experience and evidence: it is a clear systems organization failure which causes unnecessary readmissions, morbidity, costs, and likely avoidable mortality. Sad.
Poor compliance with evidence-based guide-
lines in the management of biliary pancreatitis. We must take action! #MANCTRA @salo75 @drfrancescopata @GianlucaPellino @IelpoB @FraVirdis @DimDamask @WSESurgery @ACIEuro
sciencedirect.com/science/ar…
Xavier Calvet retweeted
Can procalcitonin safely guide antibiotics in acute pancreatitis? @LancetGastroHep PROCAP study is the answer
Infographics based on the abstract, full paper: doi.org/10.1016/S2468-1253(2…
Read the Editorial by @lelecapurso and me in thelancet.com/journals/langa…
#TheAmylaseSchool @my_ueg
Xavier Calvet retweeted
Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease | NEJM Evidence evidence.nejm.org/doi/full/1…
Xavier Calvet retweeted
Enfermedad celiaca seronegativa y enteropatías cronicas no celiacas
👉Definiciones y criterios diagnósticos
🤝Consenso de expertos en Paris
gut.bmj.com/content/early/20…
Xavier Calvet retweeted
Impresionante pérdida de peso inducida por tirzepatide, en un rato muy similar al que logra la cirugía. Entramos en una nueva era del tratamiento de la obesidad.
@AEEHLiver @sepdigestiva @DigValdecilla #LiverTwitter
nejm.org/doi/pdf/10.1056/NEJ…
We presented the GETECCU updated quality criteria for IBD units at the SCD congress. Full article is already avalable at JCC
LA SCA, la CAMFIC I la SCGG avaluen conjuntament la problematica de l'Endoscopia al pacient d'edat avançada o fràgil. El document de posicionament conjunt ha estat publicat a GH i està en periode d'accés obert: authors.elsevier.com/a/1f7pn…
Xavier Calvet retweeted
Impressing results. Life of many patients will be essier, specially if @AbbVieUS @AbbVie_ES makes reasonable decisions about pricing. Otherwise payers will force biosimilars of antiTNF in most scenarios.
Xavier Calvet retweeted
The immunosuppression used in solid organ transplantation does not prevent IBD progression. Excellent presentation by @IriaBaston #somosgeteccu
Xavier Calvet retweeted
New research - Haifer et al - Lyophilised oral faecal microbiota transplantation for #ulcerativecolitis (LOTUS): a randomised, double-blind, placebo-controlled trial
thelancet.com/journals/langa…
#GITwitter #IBD #microbiome #microbiota #FMT @rupertleong
Xavier Calvet retweeted
Un honor participar en el symposium satélite de @JanssenESP en el curso #Gassull2021 de #EII junto a @nataliaborruel y @CalvetXMD
Efectividad y seguridad de nuevas estrategias, posicionamiento de fármacos y combinaciones innovadoras en pro de una mejor asistencia.
Xavier Calvet retweeted
New study: In older patients with advanced cancer, a geriatric assessment & management can reduce treatment toxicity, falls, & polypharmacy—authors say it should be considered the standard of care. hubs.li/H0_H7Ny0
Xavier Calvet retweeted
New microbe with role in #IBS?
Possible pathogenic bacteria Brachyspira found in colonic mucosa in:
IBS 19/62 = 3⃣1⃣%
Healthy controls 0/31 = 0⃣%
Presence of Brachyspira associated with diarrhoea, faster transit, inflammation
Full paper in @Gut_BMJ gut.bmj.com/content/70/6/111…
Y 2....





























